Evidence map›Paper›PMID 35733887›Full record

ArticleChemical science2022

Standard-free single magnetic bead evaluation: a stable nanoplatform for prostate disease differentiation.

Zili Huang, Xiaobo Xie, Bei Xu, Rui Liu, Jianyu Hu, Yi Lv

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zili HuangKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University Chengdu 610064 PR China lvy@scu.edu.cn.ORCID https://orcid.org/0000-0001-7312-5996
Xiaobo XieAnalytical & Testing Center, Sichuan University Chengdu 610064 PR China.
Bei XuDepartment of Clinical Laboratory, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China Mianyang 621000 PR China.
Rui LiuKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University Chengdu 610064 PR China lvy@scu.edu.cn.ORCID https://orcid.org/0000-0001-9928-5373
Jianyu HuDivision of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine & Dentistry, University of Alberta Edmonton Alberta T6G 2G3 Canada.
Yi LvKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University Chengdu 610064 PR China lvy@scu.edu.cn.ORCID https://orcid.org/0000-0002-7104-2414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Explicit interpretation of heterogeneity between prostate-specific antigen (PSA) subtypes is essential for prostate cancer differentiation during different disease courses, whereas a universal protocol with uniform criteria is still lacking across the globe. In this work, a standard-free single magnetic bead (SMB) nanoplatform utilizing metal nanoparticles with optimal diameters was proposed for prostate disease differentiation in a 134-donor model. The inaccuracy of detection in absolute quantification was diminished

Identifiers

PMID35733887
PMCPMC9159090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.